Impact of admission triglyceride for early outcome in diabetic patients with stable coronary artery disease

Table 3 Comparison of AUC among lipid profiles, glucose intolerance parameters and inflammatory biomarkers for predicted early outcome in the study population

Variables	AUC	95% CI	P-value
Lipid profiles
Fasting triglycerides	0.64	0.57-0.72	0.002
TG/HDL-C index	0.62	0.54-0.69	0.012
ApoB	0.58	0.49-0.67	0.076
Non-HDL-C	0.56	0.46-0.65	0.230
LDL-C/HDL-C ratio	0.55	0.46-0.64	0.252
ApoA	0.54	0.45-0.64	0.363
Total cholesterol	0.53	0.44-0.63	0.470
LDL-C	0.53	0.44-0.63	0.495
HDL-C	0.49	0.40-0.59	0.935
Parameters of glucose intolerance
Hemoglobin A1C	0.62	0.54-0.71	0.007
Fasting blood glucose	0.61	0.52-0.70	0.013
Inflammatory biomarkers
hs-CRP	0.55	0.46-0.63	0.293
Neutrophil count	0.53	0.44-0.61	0.557

TG/HDL-C index Triglycerides/high density lipoprotein cholesterol index, Non-HDL-C Non-High density lipoprotein cholesterol = Total cholesterol subtracts to high density lipoprotein cholesterol, LDL-C/HDL-C ratio Low density lipoprotein cholesterol/High density lipoprotein cholesterol ratio, LDL-C Low density lipoprotein cholesterol, HDL-C High density lipoprotein cholesterol, hs-CRP high sensitivity C-reactive protein.

ISSN: 1476-511X